INHIBIKASE THERAPEUTICS INC (IKT:NASDAQ)
$1.67 -0.14 (-7.7348%)
Analysed INHIBIKASE THERAPEUTICS INC (IKT:NASDAQ) News Sources
Inhibikase Therapeutics Announces Enrollment of First Patient in IMPROVE-PAH Global Phase 3 Study of IKT-001 in the Treatment of Pulmonary Arterial Hypertension
07-04-2026
yahoo.com
Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03-04-2026
yahoo.com
Inhibikase Therapeutics Announces Full Year 2025 Financial Results and Highlights Recent Activity
26-03-2026
yahoo.com
Bank of America Predicts Up to 240% Jump for These 2 ‘Strong Buy’ Stocks
22-02-2026
yahoo.com
Sands Capital Opens $10 Million ServiceTitan Position
18-02-2026
fool.com
Institutions own 29% of Inhibikase Therapeutics, Inc. (NASDAQ:IKT) shares but individual investors control 41% of the company
08-12-2025
yahoo.com
Inhibikase Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock and Pre-Funded Warrants
21-11-2025
yahoo.com
Inhibikase Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
20-11-2025
yahoo.com
Inhibikase Therapeutics Advancing IKT-001 to Global Phase 3 Study in Pulmonary Arterial Hypertension
20-11-2025
yahoo.com
Inhibikase Therapeutics Announces Third Quarter 2025 Financial Results and Highlights Recent Activity
14-11-2025
yahoo.com
What is the current price of INHIBIKASE THERAPEUTICS INC (IKT:NASDAQ)?
The current price of INHIBIKASE THERAPEUTICS INC (IKT:NASDAQ) is $1.67.
INHIBIKASE THERAPEUTICS INC (IKT:NASDAQ) absolute price change since previous trading day?
The absolute price change of INHIBIKASE THERAPEUTICS INC (IKT:NASDAQ) since the previous trading day is $-0.14.
INHIBIKASE THERAPEUTICS INC (IKT:NASDAQ) percentage price change since previous trading day?
The percentage price change of INHIBIKASE THERAPEUTICS INC (IKT:NASDAQ) since the previous trading day is -7.7348%.
What is the most recent average sentiment score for INHIBIKASE THERAPEUTICS INC (IKT:NASDAQ)?
The most recent average sentiment score for INHIBIKASE THERAPEUTICS INC (IKT:NASDAQ) is 79 out of 100.
What is the most recent average sentiment for INHIBIKASE THERAPEUTICS INC (IKT:NASDAQ)?
The most recent sentiment for INHIBIKASE THERAPEUTICS INC (IKT:NASDAQ) is .
SEC-8K** Filing Available For INHIBIKASE THERAPEUTICS INC (IKT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.